Jounce Therapeutics (JNCE) PT Raised to $35 at Baird

March 8, 2018 12:05 PM

Baird analyst Michael Ulz raised his price target on Jounce Therapeutics (NASDAQ: JNCE) to $35.00 (from $30.00) while maintaining aanOutperform ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found